Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)

.

Source: Expert Opinion on Therapeutic Patents - March 28, 2023 Category: Drugs & Pharmacology Authors: Lijuan Xu Wannian Zhang Chunlin Zhuang Source Type: research